Anlin Ma

机构：Universiti Putra Malaysia, Minzu University of China, Jinggangshan University, National University of Singapore, Capital Medical University, China-Japan Friendship Hospital, Wuhan University, National Clinical Research Center for Digestive Diseases, Renmin Hospital of Wuhan University, Beijing Friendship Hospital

发表论文 64 篇 · 总被引 722 次 · h-index 17

代表论文

• A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease (2024 · Hepatology International · 被引 33)
• Single-dose suraxavir marboxil for acute uncomplicated influenza in adults and adolescents: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial (2025 · Nature Medicine · 被引 20)
• A review of the pathogenesis of mitochondria in breast cancer and progress of targeting mitochondria for breast cancer treatment (2025 · Journal of Translational Medicine · 被引 19)
• Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients (2023 · Clinical and Molecular Hepatology · 被引 12)
• Spatial Transcriptomics Decodes Breast Cancer Microenvironment Heterogeneity: From Multidimensional Dynamic Profiling to Precision Therapy Blueprint Construction (2025 · Biomolecules · 被引 11)
• Lower end of treatment HBsAg and HBcrAg were associated with HBsAg loss after nucleos(t)ide analog cessation (2023 · BMC Gastroenterology · 被引 10)